Pedro Luis Sánchez Fernández-rekin lankidetzan egindako argitalpenak (31)

2023

  1. Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

    Cancers, Vol. 15, Núm. 17

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Cardiac magnetic resonance to detect different patterns of myocardial injury in patients receiving immune checkpoint inhibitors

    Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 266-269

  2. Mean Velocity of the Pulmonary Artery as a Clinically Relevant Prognostic Indicator in Patients with Heart Failure with Preserved Ejection Fraction

    Journal of Clinical Medicine, Vol. 11, Núm. 3

  3. Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers

    Revista Espanola de Cardiologia, Vol. 75, Núm. 9, pp. 735-747

2021

  1. Early experience in the multidisciplinary care (pediatricians and cardiologists) of adults with congenital heart disease

    Revista Espanola de Cardiologia, Vol. 74, Núm. 8, pp. 714-716

  2. Magnetic resonance myocardial feature tracking in transfusion-dependent myelodysplastic syndrome

    Journal of Cardiovascular Imaging, Vol. 29, Núm. 4, pp. 331-344

  3. Predictors of cardiovascular events and all-cause of death in patients with transfusion-dependent myelodysplastic syndrome

    British Journal of Haematology, Vol. 195, Núm. 4, pp. 536-541

  4. Usefulness of myocardial T1 and T2 mapping with magnetic resonance in transfusion-dependent patients with low-risk myelodysplastic syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 630-633

2020

  1. Acute myocarditis: phenocopy of apical hypertrophic cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 1063

  2. Effectiveness of sacubitril–valsartan in cancer patients with heart failure

    ESC Heart Failure, Vol. 7, Núm. 2, pp. 763-767

  3. Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 73, Núm. 3, pp. 268-269

  4. T2 Mapping Identifies Early Anthracycline-Induced Cardiotoxicity in Elderly Patients With Cancer

    JACC: Cardiovascular Imaging

2019

  1. Effectiveness of first versus successive antitachycardia pacing attempts: predictors and clinical consequences

    Journal of Interventional Cardiac Electrophysiology, Vol. 56, Núm. 3, pp. 349-357

  2. SALMANTICOR study. Rationale and design of a population-based study to identify structural heart disease abnormalities: A spatial and machine learning analysis

    BMJ Open, Vol. 9, Núm. 2

  3. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity

    Journal of the American College of Cardiology, Vol. 73, Núm. 7, pp. 779-791

2018

  1. First Magnetic Resonance Managed by a Cardiology Department in the Spanish Public Healthcare System. Experience and Difficulties of an Innovative Model

    Revista Espanola de Cardiologia, Vol. 71, Núm. 5, pp. 365-372

  2. Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome

    Heart, Vol. 104, Núm. 1, pp. 45-50

  3. Response by Fernández-Jiménez et al to Letters Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage"

    Circulation

  4. Severely complicated emergency blind pericardiocentesis: Evidence from multimodality imaging

    Revista Portuguesa de Cardiologia, Vol. 37, Núm. 10, pp. 867-868